COVID-19 Vaccination Acceptability: A Cross-Sectional Study Among Lebanese Residents
Authors:
- 30 June 2023
- journal article
- research article
- Published by Cambridge University Press (CUP) in Disaster Medicine and Public Health Preparedness
- Vol. 17, e421
Abstract
Objective: Concerns about the side effects of available coronavirus disease (COVID-19) vaccines have posed a significant barrier to vaccination in several countries. Accordingly, the current study aimed to assess the acceptability of COVID-19 vaccination and its predictors among the Lebanese population. Methods: A cross-sectional study was conducted in February 2021 among Lebanese adults from the 5 main Lebanese districts. The questionnaire included demographic data, questions about COVID-19 experience, COVID-19 anxiety syndrome scale, and attitudes regarding the COVID-19 vaccine. Data were analyzed on SPSS, version 23. Statistical significance was considered at a P value ≤ 0.05 with a 95% CI. Results: Of 811 participants, 45.4% (95% CI: 41.9-48.9) accepted taking the COVID-19 vaccine. Choices were negatively affected by concerns about the side effects of the vaccine and positively affected by anxiety and seeking COVID-19 news very closely. Moreover, if the COVID-19 vaccination was a requirement for traveling, participants would be more willing to get the vaccine. Conclusions: Since 54.7% of the studied Lebanese adults were either unwilling or undecided to get the vaccine and COVID-19 news was retrieved mainly from the Ministry of Public Health online site and the local news, the existing targeted campaign should be enforced toward encouraging vaccination to reach herd immunity against COVID-19 and revealing the safety of the vaccines.Keywords
This publication has 16 references indexed in Scilit:
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in RussiaThe Lancet, 2021
- Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communicationsThe Lancet Regional Health - Europe, 2021
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trialThe Lancet Infectious Diseases, 2021
- Acceptance of a COVID-19 Vaccine and Its Related Determinants among the General Adult Population in KuwaitMedical Principles and Practice, 2021
- A global survey of potential acceptance of a COVID-19 vaccineNature Medicine, 2020
- Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United StatesVaccines, 2020
- The COVID-19 anxiety syndrome scale: Development and psychometric propertiesPsychiatry Research, 2020
- A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 PandemicFrontiers in Pharmacology, 2020
- Vaccine Safety: Myths and MisinformationFrontiers in Microbiology, 2020